Chemstream Acquires Synthex Organics

Formosa Laboratories Acquires SynChem to Expand North American CDMO Footprint

June 3, 2024

Pharmaceuticals

Formosa Laboratories, Inc., a Taiwan-based API supplier and CDMO, has completed its acquisition of SynChem, Inc., a contract research laboratory in suburban Chicago. SynChem will operate as SynChem-Formosa with Dr. W. Paul Mar remaining as CEO as the combined operations expand Formosa's US CDMO capabilities for small-molecule APIs and ADC-related chemistries.

Synalloy Corporation Acquires DanChem from Edgewater Capital Partners

October 28, 2021

Manufacturing

Synalloy Corporation (Nasdaq: SYNL) acquired DanChem, a specialty-chemicals contract manufacturer based in Danville, Virginia, for $32.95 million, closing October 22, 2021. DanChem operates three production plants on a 55-acre campus with over 120 employees, and is expected to generate approximately $30 million of 2021 revenue (c.18% adjusted EBITDA); the deal was funded through Synalloy's existing credit facility and DanChem was an Edgewater Capital Partners portfolio company.

Seatex Acquires ChemQuest Chemicals

September 7, 2022

Manufacturing

Seatex, a specialty chemical manufacturer backed by Cotton Creek Capital, has acquired ChemQuest Chemicals, a custom toll manufacturer headquartered in Pasadena, Texas. The deal, completed in September 2022, expands Seatex's production capacity and technical capabilities while providing continuity for ChemQuest customers; Edgewater Capital Partners, ChemQuest's private equity owner, sold the business.

X-Chem Acquires IntelliSyn and AviSyn to Expand Drug Discovery Services

January 26, 2021

Biotechnology

X-Chem, a portfolio company of GHO Capital, has acquired Montreal-based IntelliSyn and its US-based sister company AviSyn to extend its drug discovery offering into medicinal chemistry, custom synthesis and scale-up process chemistry. The deal integrates downstream hit validation and lead optimisation capabilities into X-Chem’s DNA-Encoded Library (DEL) platform, enabling a streamlined screen-to-lead service for pharma and biotech clients; financial terms were not disclosed.

eMolecules Acquires Synple Chem AG

September 24, 2024

Biotechnology

eMolecules, a San Diego-based provider of a chemical compound search-and-fulfillment platform and a portfolio company of Avista Healthcare Partners, has acquired Synple Chem AG, an automated chemical synthesis systems and services provider headquartered near Zurich, Switzerland. The acquisition adds Synple's automation technology and a virtual compound library of more than 7 trillion tractable compounds to eMolecules' existing offering, expanding its capabilities as a one-stop shop for compound procurement, management and automation for drug discovery customers.

Chemtrade Acquires Polytec, Inc.

November 21, 2025

Environmental Services

Chemtrade Logistics Income Fund completed the acquisition of Polytec, Inc., a southeastern U.S. turnkey water treatment solutions provider, for US$150 million. The deal expands Chemtrade's water-treatment chemicals platform by adding Polytec's service capabilities, products and end-market access (municipal and food-processing) to support cross-selling and Vision 2030 growth targets.